Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis

Authors

Institutions

Publication Details

Journal
EBioMedicine
Published
2024-12-06
DOI
https://doi.org/10.1016/j.ebiom.2024.105485
Citations
11
Primary Topic
Psoriasis: Treatment and Pathogenesis
Type
article
Field-Weighted Citation Impact
2.65

Funders

Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis

Gema Hernandez, Ralf Joachim Ludwig, Henner Zirpel, Eva Lotta Moderegger et al.
11 citations
EBioMedicine
Psoriasis: Treatment and Pathogenesis
2.65
article

Biological, as opposed to classic antipsoriatic drug or apremilast, treatment mitigates the risk of death and cardiovascular disease in psoriasis

Gema Hernandez, Ralf Joachim Ludwig, Henner Zirpel, Eva Lotta Moderegger, Katja Bieber, Khalaf Kridin, Artem Vorobyev, Henning Olbrich, Diamant Thaçi, Bernard Gershater, Marlene A. Ludwig
article en
11 citations

Abstract

No abstract available for this paper.
EBioMedicineVol. 111
Universitäres Kinderwunschzentrum Lübeck (DE), University Hospital Schleswig-Holstein (DE), Universidad Politécnica de Madrid (ES), University of Lübeck (DE)
Deutsche Forschungsgemeinschaft
Good health and well-being
Openalex Percentile: Top 9%
Psoriasis: Treatment and Pathogenesis
2.65
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.